Drug Enforcement Administration 2010 – Federal Register Recent Federal Regulation Documents

Results 101 - 150 of 223
Hung Thien Ly, M.D.; Revocation of Registration
Document Number: 2010-20209
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Peter W.S. Grigg, M.D.; Revocation of Registration
Document Number: 2010-20201
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Nicholas J. Jerrard, M.D.; Revocation of Registration
Document Number: 2010-20194
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Beverley P. Edwards, M.D.; Revocation of Registration
Document Number: 2010-20193
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
James Stephen Ferguson, D.M.D.; Revocation of Registration
Document Number: 2010-20192
Type: Notice
Date: 2010-08-16
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances; Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act; Correction
Document Number: 2010-19348
Type: Rule
Date: 2010-08-06
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is correcting a final rule that appeared in the Federal Register of March 18, 2004. The final rule pertained to the scheduling of N-Benzylpiperazine (BZP), and contained an error regarding the potency of BZP relative to amphetamine. Although DEA used the correct figures in arriving at its scheduling determination, the agency is publishing this correction to provide an official statement of the actual figures. This correction
Schedules of Controlled Substances; Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act; Correction
Document Number: 2010-19345
Type: Proposed Rule
Date: 2010-08-06
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is correcting a notice of proposed rulemaking that appeared in the Federal Register of September 8, 2003. The proposed rule pertained to the scheduling of N- Benzylpiperazine (BZP), and contained an error regarding the potency of BZP relative to amphetamine. Although DEA used the correct figures in arriving at its scheduling determination, the agency is publishing this correction to provide an official statement of the actual figures. This
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-19078
Type: Notice
Date: 2010-08-04
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2010-18500
Type: Notice
Date: 2010-07-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2010-18495
Type: Notice
Date: 2010-07-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-18486
Type: Notice
Date: 2010-07-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2010-18485
Type: Notice
Date: 2010-07-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2010-18483
Type: Notice
Date: 2010-07-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-18476
Type: Notice
Date: 2010-07-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances: Notice of Registration
Document Number: 2010-18475
Type: Notice
Date: 2010-07-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances: Notice of Application
Document Number: 2010-18474
Type: Notice
Date: 2010-07-28
Agency: Drug Enforcement Administration, Department of Justice
Removal of Thresholds for the List I Chemicals Pseudoephedrine and Phenylpropanolamine
Document Number: 2010-16388
Type: Rule
Date: 2010-07-07
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is removing the thresholds for importation, exportation, and domestic distributions of the List I chemicals pseudoephedrine and phenylpropanolamine. This rulemaking is being conducted as part of DEA's implementation of the Combat Methamphetamine Epidemic Act of 2005 and is needed to implement
Dispensing of Controlled Substances to Residents at Long Term Care Facilities
Document Number: 2010-15757
Type: Notice
Date: 2010-06-29
Agency: Drug Enforcement Administration, Department of Justice
To analyze ongoing issues related to the dispensing of controlled substances to residents residing at long term care facilities (LTCFs), DEA is soliciting information on this subject from practitioners, pharmacists, LTCFs, nurses, residents and family of residents in long term care facilities, State regulatory agencies, and other interested members of the public. Specifically, DEA is exploring whetherwhile adhering to the framework of the Controlled Substances Actany further revisions to the DEA regulations are feasible and warranted toward the goal of making it easier for residents of LTCFs to receive controlled substance medications. This notice recites the pertinent statutory considerations and contains a series of questions designed to elicit public comment that will assist DEA in making this evaluation.
Correction of Code of Federal Regulations: Removal of Temporary Listing of Benzylfentanyl and Thenylfentanyl as Controlled Substances
Document Number: 2010-15529
Type: Rule
Date: 2010-06-29
Agency: Drug Enforcement Administration, Department of Justice
This rulemaking corrects Title 21 Code of Federal Regulations (CFR) by deleting regulations which list the substances benzylfentanyl and thenylfentanyl as being temporarily subject to schedule I controls under the emergency scheduling provisions of the Controlled Substances Act (CSA). The temporary scheduling of benzylfentanyl and thenylfentanyl expired on November 29, 1986. DEA determined that these compounds were both essentially inactive, with no evidence of abuse potential. As such, these compounds are no longer schedule I controlled substances and all references to these compounds are being deleted from DEA regulations.
Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance
Document Number: 2010-15520
Type: Rule
Date: 2010-06-29
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is designating the precursor chemical, 4-anilino-N-phenethyl-4-piperidine (ANPP) as an immediate precursor for the schedule II controlled substance fentanyl under the definition set forth in 21 U.S.C. 802(23). Furthermore, DEA is finalizing the control of ANPP as a schedule II substance under the Controlled Substances Act (CSA), pursuant to the authority in 21 U.S.C. 811(e), which states that an immediate precursor may be placed in the same schedule as the controlled substance it produces, without regard to the procedures required by 21 U.S.C. 811(a) and (b) and without regard to the findings required by 21 U.S.C. 811(a) and 812(b).
Exempt Chemical Mixtures Containing Gamma-Butyrolactone
Document Number: 2010-15518
Type: Rule
Date: 2010-06-29
Agency: Drug Enforcement Administration, Department of Justice
This rulemaking finalizes a November 12, 2008, Notice of Proposed Rulemaking in which DEA proposed that chemical mixtures that are 70 percent or less gamma-butyrolactone (GBL), by weight or volume, be automatically exempt from regulatory controls under the Controlled Substances Act (CSA). DEA is seeking through this rulemaking to exempt only those chemical mixtures that do not represent a significant risk of diversion. This regulation makes GBL chemical mixtures, in concentrations greater than 70 percent, subject to List I chemical regulatory requirements of the CSA, except if exempted through an existing categorical exemption. DEA is taking this action because there is a serious threat to the public safety associated with the ease by which GBL is chemically converted to the schedule I controlled substance gamma-hydroxybutyric acid (GHB).
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-15559
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Application
Document Number: 2010-15558
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-15557
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-15556
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-15555
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-15530
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-15528
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-15527
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-15526
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Proposed Revised Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2010
Document Number: 2010-15525
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
This notice proposes revised 2010 assessment of annual needs for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Importer of Controlled Substances; Notice of Application
Document Number: 2010-15524
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-15523
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-15522
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-15519
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Notice of Application
Document Number: 2010-15517
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-15516
Type: Notice
Date: 2010-06-28
Agency: Drug Enforcement Administration, Department of Justice
Chemical Mixtures Containing Listed Forms of Phosphorus and Change in Application Process
Document Number: 2010-15160
Type: Proposed Rule
Date: 2010-06-25
Agency: Drug Enforcement Administration, Department of Justice
The DEA is proposing regulations which establish those chemical mixtures containing red phosphorus, white phosphorus (also known as yellow phosphorus), or hypophosphorous acid and its salts (hereinafter ``regulated phosphorus'') that shall automatically qualify for exemption from the Controlled Substances Act (CSA) regulatory controls. DEA is proposing that chemical mixtures containing red phosphorus in a concentration of 80 percent or less and mixtures containing hypophosphorous acid and its salts (hypophosphite salts) in a concentration of 30 percent and less, shall qualify for automatic exemption. DEA is not proposing automatic exemption for chemical mixtures containing white phosphorus. Unless otherwise exempted, all material containing white phosphorus shall become subject to CSA chemical regulatory controls regardless of concentration.
Controlled Substances: Proposed Revised Aggregate Production Quotas for 2010
Document Number: 2010-15159
Type: Notice
Date: 2010-06-23
Agency: Drug Enforcement Administration, Department of Justice
This notice proposes revised 2010 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA).
Importer of Controlled Substances; Notice of Application
Document Number: 2010-13756
Type: Notice
Date: 2010-06-08
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-13752
Type: Notice
Date: 2010-06-08
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2010-13751
Type: Notice
Date: 2010-06-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-13747
Type: Notice
Date: 2010-06-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-13738
Type: Notice
Date: 2010-06-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 2010-13737
Type: Notice
Date: 2010-06-08
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.